Jeegar Pravinkumar Patel
CIK: 0002092017
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Evommune, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 22, 2026EVMN
Evommune, Inc.
Sale(S)Direct1.5K shares at avg. $22.50$33K - Jun 22, 2026EVMN
Evommune, Inc.
Exercise(M)Direct1.5K shares at avg. $3.84$6K - Jun 1, 2026EVMN
Evommune, Inc.
Exercise(M)Direct13.5K shares at avg. $3.84$52K - Jun 1, 2026EVMN
Evommune, Inc.
Sale(S)Direct16.7K shares at avg. $22.74$379K - Apr 16, 2026EVMN
Evommune, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
69.3K shares- - Dec 9, 2025EVMN
Evommune, Inc.
Tax Payment(F)Direct7.5K shares at avg. $17.84$134K - Nov 7, 2025EVMN
Evommune, Inc.
Conversion(C)Direct3.2K shares- - Nov 5, 2025EVMN
Evommune, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
179.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 | EVMN Evommune, Inc. | Sale(S) | 1,488 | $22.50 | $33,480 | Direct |
| Jun 22, 2026 | EVMN Evommune, Inc. | Exercise(M) | 1,488 | $3.84 | $5,714 | Direct |
| Jun 1, 2026 | EVMN Evommune, Inc. | Exercise(M) | 13,512 | $3.84 | $51,886 | Direct |
| Jun 1, 2026 | EVMN Evommune, Inc. | Sale(S) | 16,687 | $22.74 | $379,462 | Direct |
| Apr 16, 2026 | EVMN Evommune, Inc. | Award(A) Employee Stock Option (Right to Buy) | 69,315 | - | - | Direct |
| Dec 9, 2025 | EVMN Evommune, Inc. | Tax Payment(F) | 7,513 | $17.84 | $134,032 | Direct |
| Nov 7, 2025 | EVMN Evommune, Inc. | Conversion(C) | 3,175 | - | - | Direct |
| Nov 5, 2025 | EVMN Evommune, Inc. | Award(A) Employee Stock Option (Right to Buy) | 179,619 | - | - | Direct |
1-8 of 8 transactions
About Patel Jeegar Pravinkumar
Patel Jeegar Pravinkumar (SEC CIK 0002092017) files insider reports with the SEC as Chief Scientific Officer of Evommune, Inc. (EVMN).
Signal8 holds 7 ownership filings by Patel Jeegar Pravinkumar (1 Form 3, 6 Form 4), filed between Nov 5, 2025 and Jun 24, 2026. Those filings report 8 transactions, from Nov 5, 2025 to Jun 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Patel Jeegar Pravinkumar's filings is in PALO ALTO, CA.
Recent filings by Patel Jeegar Pravinkumar
- Jun 22, 2026: Open-market sale of EVMN shares (Form 4, code S).
- Jun 22, 2026: Option exercise of EVMN shares (Form 4, code M).
- Jun 1, 2026: Option exercise of EVMN shares (Form 4, code M).
- Jun 1, 2026: Open-market sale of EVMN shares (Form 4, code S).
- Apr 16, 2026: Grant or award of EVMN derivative securities (Form 4, code A).
Other insiders filing for Evommune, Inc. (EVMN)
- Pena Luis C., President & CEO
- Carver Kyle, Chief Financial Officer
- KIRSCH ARTHUR S, Director
- Drew Janice Suzann, Chief of Dev. Operations
- MCGRAW BENJAMIN F III, Director
- Cohen David E, Director